Eurobio Scientific Société anonyme (EPA:ALERS)
France flag France · Delayed Price · Currency is EUR
24.00
+1.20 (5.26%)
Apr 24, 2026, 2:08 PM CET

EPA:ALERS Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Other Revenue
--0---
169154.95130.65152.9185.32
Revenue Growth (YoY)
9.07%18.60%-14.56%-17.50%-2.04%
Cost of Revenue
91.782.9973.1681.6685.91
Gross Profit
77.371.9557.4971.2499.41
Selling, General & Admin
5338.8633.523124.5
Research & Development
4.64.655.913.47-
Amortization of Goodwill & Intangibles
8.98.527.925.94.79
Operating Expenses
66.552.0247.3540.3729.29
Operating Income
10.819.9310.1430.8770.12
Interest Expense
-2.9-4.13-4.36-1.26-0.41
Interest & Investment Income
-1.481.120.04-
Currency Exchange Gain (Loss)
-0.690.750.670.36
Other Non Operating Income (Expenses)
-0.1-3.710.770.04-0.05
EBT Excluding Unusual Items
7.814.268.4230.3570.01
Merger & Restructuring Charges
--6.6---
Gain (Loss) on Sale of Investments
----0.23
Other Unusual Items
--1.38-1.45-0.671.08
Pretax Income
7.86.286.9829.6871.31
Income Tax Expense
2.92.292.144.7510.77
Earnings From Continuing Operations
4.944.8424.9460.54
Net Income
4.944.8424.9460.54
Net Income to Common
4.944.8424.9460.54
Net Income Growth
22.56%-17.31%-80.61%-58.81%-17.61%
Shares Outstanding (Basic)
-10111111
Shares Outstanding (Diluted)
-10111111
Shares Change (YoY)
--8.49%-1.40%4.59%-3.35%
EPS (Basic)
-0.390.432.205.58
EPS (Diluted)
-0.390.432.205.57
EPS Growth
--9.42%-80.44%-60.53%-14.70%
Free Cash Flow
-13.4522.7140.2464.07
Free Cash Flow Per Share
-1.312.023.545.89
Gross Margin
45.74%46.44%44.00%46.59%53.64%
Operating Margin
6.39%12.86%7.76%20.19%37.84%
Profit Margin
2.90%2.58%3.70%16.31%32.67%
Free Cash Flow Margin
-8.68%17.39%26.32%34.57%
EBITDA
20.3129.4523.2940.577.98
EBITDA Margin
12.02%19.00%17.82%26.49%42.08%
D&A For EBITDA
9.519.5113.159.637.87
EBIT
10.819.9310.1430.8770.12
EBIT Margin
6.39%12.86%7.76%20.19%37.84%
Effective Tax Rate
37.18%36.38%30.70%15.99%15.10%
Revenue as Reported
169154.95130.65152.9185.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.